Systemic absorption of oral vancomycin in patients with Clostridium difficile infection

Author： Rao Sriharsha Kupfer Yizhak Pagala Murali Chapnick Edward Tessler Sidney

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.43, Iss.5, 2011-05, pp. : 386-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis

By Chihara Shingo Shimizu Riha Furukata Satoshi Hoshino Koichi

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 2, 2011-02 ,pp. : 149-150

Informa Healthcare

Access to resources Recommend Favorite

Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment of Clostridium difficile Infection

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 119-126

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clostridium difficile infection in hospitalized octogenarian patients

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 18, Iss. 2, 2018-02 ,pp. : 315-320

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 835-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Appropriateness of empiric therapy in patients with suspected Clostridium difficile infection

By Saade Elie

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 985-988

Informa Healthcare

Access to resources Recommend Favorite